Not investment advice. Educational reading. See Disclaimer.
L.5 · INTERMEDIATE · 2 MIN
The Football Field: Presenting Your Valuation
Investment bankers present valuations using a ‘football field’ chart — overlapping horizontal bars showing the value range from each methodology. Where all methods overlap is the zone of fair value.
When methods converge on a narrow range, confidence is high. When they diverge wildly, revisit your assumptions — one methodology may be using stale data, incorrect comps, or unrealistic growth rates.
§ 03Step through
The football field is a presentation tool, not an analytical shortcut. Each bar requires a full analysis behind it. The power is in the convergence — or divergence — of independent methodologies.
Pattern
What It Means
Action
All methods overlap
High confidence in value range
Invest if price is below the overlap zone
DCF higher than comps
Your growth assumptions may be too optimistic
Pressure-test DCF inputs
Precedents much higher
Control premium is large or deals were done at peak
Don't apply M&A premiums to minority stakes
52-week range far below
Market has repriced the sector
Check if fundamentals changed
§ 04Try it
For a company you’re analyzing, sketch out a football field: What do comps suggest? What would a DCF give you? Where has the stock traded in the last year? Do the ranges overlap?
§ 05Check-in
Your football field shows DCF at $70–$95, comps at $65–$85, and the stock at $60. Is this a buy?
§ 06Key insight
The football field is the final output of a valuation exercise, not the starting point. It forces you to triangulate from multiple angles — and the zone where independent methods agree is where your conviction should be highest.
§ 07Check-in
You've done DCF ($130), multiples ($145 mid-range), and precedent transactions ($160 adjusted for control). What's Company Z really worth?
Check your understanding
●○○○○
Sit with the ideas.
Your analysis produces these per-share values: Trading comps: $80-$100. Precedent transactions: $110-$130. DCF: $85-$115. 52-week range: $70-$105. The stock trades at $88. What is your recommendation?